Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age.
Tesser, John
Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age. [electronic resource] - Arthritis research & therapy 08 2019 - 190 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1478-6362
10.1186/s13075-019-1968-x doi
Age Factors
Aged
Antibodies, Monoclonal--administration & dosage
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--diagnosis
Disease Progression
Dose-Response Relationship, Drug
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Infusions, Intravenous
Male
Methotrexate--administration & dosage
Middle Aged
Treatment Outcome
Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age. [electronic resource] - Arthritis research & therapy 08 2019 - 190 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1478-6362
10.1186/s13075-019-1968-x doi
Age Factors
Aged
Antibodies, Monoclonal--administration & dosage
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--diagnosis
Disease Progression
Dose-Response Relationship, Drug
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Infusions, Intravenous
Male
Methotrexate--administration & dosage
Middle Aged
Treatment Outcome